Nimit Singhal

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Prevalence and factors associated with polypharmacy in older people with cancer

Justin P. Turner, Sepehr Shakib, Nimit Singhal et al. · Supportive Care in Cancer · 2014 · 144 citations

Geriatric Oncology, Oncology, Cancer Epidemiology +13

Polypharmacy cut-points in older people with cancer: how many medications are too many?

Justin P. Turner, Kris M. Jamsen, Sepehr Shakib et al. · Supportive Care in Cancer · 2015 · 130 citations

Oncology, Medicine, Cancer Management +7

Response to erlotinib in a patient with treatment refractory chordoma

Nimit Singhal, Dusan Kotasek, Francis Parnis · Anti-Cancer Drugs · 2009 · 78 citations

Tumor Biology, Surgical Oncology, Tumoral Pathology +15

Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey

Éléna Paillaud, Pierre Soubeyran, Philippe Caillet et al. · European Journal of Cancer · 2018 · 68 citations

Geriatric Oncology, Geriatric Core Dataset, Aging +11